Clinical trial
17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or…
NCT00089271 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00089271 |
|---|---|
| Title | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas |
| Official title | A Phase I Study Of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin, (17-DMAG) (NSC 707545) In Patients With Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma and 41 more |
| Intervention type | Drug, Other |
| Interventions | alvespimycin hydrochloride, laboratory biomarker analysis |
| Enrollment | 60 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2010 |
| First posted | Aug 5, 2004 |
| Last update posted | Jan 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: